Literature DB >> 3522617

The dawn phenomenon does not occur in normal elderly subjects.

G S Meneilly, D Elahi, K L Minaker, J W Rowe.   

Abstract

To determine whether the dawn phenomenon occurs in normal elderly subjects and thus contributes to the progressive mild fasting hyperglycemia of aging, we examined the effect of physiological insulin levels on glucose disposal and hepatic glucose production (HGO) between 0530 and 0800 h, and 0930 and 1200 h. Paired euglycemic insulin clamp studies (8 mU/m2 X min) were performed on healthy old subjects (n = 5), employing [3H]glucose methodology to measure glucose production and disposal rates. Basal plasma insulin, GH, glucagon, and cortisol levels, and HGO and glucose disposal rates were similar before each study. Steady state plasma insulin values were slightly, but not significantly, lower during the dawn study [dawn: 20.3 +/- 1.1 (SE); control: 23.5 +/- 2.1 microU/ml, P = 0.08]. Insulin clearance rates were higher during the dawn study (dawn: 523 +/- 16; control: 430 +/- 19 ml/m2 X min, P less than 0.01). Maximum glucose disposal rates (dawn: 3.10 +/- 0.24; control: 3.03 +/- 0.23 mg/kg X min) and minimum HGO levels (dawn: 0.83 +/- 0.09; control: 0.62 +/- 0.03 mg/kg X min) were not significantly different in each part of the study. There was a significant decrease in plasma GH during the dawn (P less than 0.01, analysis of variance) but not the control studies. There was no difference in cortisol levels during the euglycemic clamp between the dawn and control studies. The mean decrement in glucagon during the insulin infusion was similar in each part of the study. We conclude that the dawn phenomenon does not occur in healthy elderly subjects despite an increase in insulin clearance during the dawn period.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3522617     DOI: 10.1210/jcem-63-2-292

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

Review 1.  Advances in the treatment of diabetes mellitus in the elderly. Development of insulin analogues.

Authors:  B J Hoogwerf; A Mehta; S Reddy
Journal:  Drugs Aging       Date:  1996-12       Impact factor: 3.923

2.  Frequency and severity of the dawn phenomenon in type 2 diabetes: relationship to age.

Authors:  Louis Monnier; Claude Colette; Mathieu Sardinoux; Gregory Baptista; Alyne Regnier-Zerbib; David Owens
Journal:  Diabetes Care       Date:  2012-09-18       Impact factor: 19.112

3.  Prognostic value of vascular endothelial growth factor receptor 1 and class III β-tubulin in survival for non-metastatic rectal cancer.

Authors:  Xiang-Quan Kong; Yun-Xia Huang; Jin-Luan Li; Xue-Qing Zhang; Qing-Qin Peng; Li-Rui Tang; Jun-Xin Wu
Journal:  World J Gastrointest Oncol       Date:  2018-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.